influenza
infect
major
caus
morbid
mortal
worldwid
especi
pandem
outbreak
emerg
data
indic
phase
ii
antioxid
enzym
pathway
could
play
role
virusassoci
inflamm
immun
clearanc
gene
express
known
modifi
inflamm
mechanist
role
viral
suscept
clearanc
yet
elucid
therefor
util
differenti
human
nasal
epitheli
cell
nec
enzymat
viruslik
particl
entri
assay
examin
role
gene
express
viral
entri
replic
herein
lentivir
vector
express
short
hairpin
sh
rna
effect
decreas
mrna
protein
express
transduc
human
nec
healthi
volunt
knockdown
correl
signific
increas
influenza
viru
entri
replic
convers
supplement
potent
activ
sulforaphan
sfn
epigallocatechin
gallat
egcg
significantli
decreas
viral
entri
replic
suppress
effect
egcg
viral
replic
abolish
cell
knockeddown
express
suggest
causal
relationship
egcginduc
activ
abil
protect
viral
infect
interestingli
induct
via
nutrit
supplement
sfn
egcg
increas
antivir
mediatorsrespons
rigi
mxa
baselin
absenc
infect
data
indic
invers
relationship
level
express
viral
entri
replic
also
demonstr
supplement
antioxid
inhibit
viral
replic
human
nec
may
prove
attract
therapeut
intervent
taken
togeth
data
indic
potenti
mechan
gene
express
regul
suscept
influenza
human
epitheli
cell
influenza
infect
major
caus
morbid
mortal
worldwid
especi
recent
pandem
unit
state
alon
peopl
die
individu
hospit
everi
year
due
influenza
virusrel
diseas
influenza
virus
caus
annual
epidem
recur
pandem
potenti
sever
consequ
global
public
health
despit
largescal
effort
vaccin
antivir
therapi
morbid
mortal
associ
influenza
infect
significantli
chang
recent
year
latest
influenza
pandem
caus
viru
thu
far
result
million
case
worldwid
epidemiolog
studi
show
highrisk
group
includ
infant
elderli
immun
compromis
individu
suscept
influenza
viru
infect
context
potenti
pandem
respiratori
viral
infect
import
identifi
protect
suscept
subpopul
identif
molecular
targetspathway
therapeut
intervent
despit
larg
volum
publish
data
implic
age
preexist
diseas
nutrit
defici
impair
innat
immun
respons
influenc
suscept
infect
mechan
viral
suscept
complex
yet
elucid
studi
shown
oxid
stress
associ
increas
suscept
sever
respiratori
viral
infect
includ
influenza
viru
infect
number
factor
may
influenc
suscept
influenza
infect
human
airway
specif
oxid
air
pollut
cigarett
smoke
diesel
exhaust
ozon
oxid
stress
caus
imbal
product
reactiv
oxygen
speci
ro
bodi
abil
readili
detoxifi
reactiv
intermedi
enzym
includ
phase
ii
antioxid
hemeoxygenas
regul
transcript
factor
factor
induct
antioxid
enzym
prevent
slow
oxid
damag
cell
emerg
data
indic
play
import
role
develop
cancer
chronic
lung
diseas
defens
oxid
well
host
defens
respiratori
viral
infect
although
shown
oxid
stress
increas
sever
viral
infect
exact
mechan
happen
role
respons
fulli
understood
sinc
airway
epitheli
cell
major
sourc
antioxid
enzym
product
primari
target
influenza
viru
infect
replic
import
determin
role
cellular
antioxid
viral
pathogenesi
infect
epitheli
cell
respond
produc
numer
cytokin
immunoregulatori
molecul
antivir
mediat
compon
host
innat
immun
respons
one
princip
mediat
respons
type
interferon
secret
virusinfect
cell
requir
induc
synthesi
andor
activ
mediat
involv
turn
viral
replic
within
host
cell
although
act
autocrin
fashion
inhibit
viral
replic
within
infect
cell
primarili
function
paracrin
mode
protect
neighbor
cell
yet
infect
potent
stimuli
type
ifn
synthesi
signal
deriv
viral
infect
specif
recognit
doublestrand
rna
produc
virus
replic
process
anoth
hallmark
influenza
viru
sensit
inhibitori
effect
ifninduc
mxgtpase
mxa
significantli
abrog
viral
replic
howev
role
antioxid
modul
interferon
antivir
respons
epitheli
cell
studi
studi
use
establish
cell
cultur
model
differenti
human
nasal
epitheli
cell
nec
gener
lentivir
vector
express
short
hairpin
sh
rna
determin
role
suscept
influenza
infect
show
shrna
effect
decreas
mrna
protein
express
cell
correl
significantli
increas
viral
entri
replic
transduc
human
nec
importantli
directli
show
invers
relationship
level
express
suscept
viral
infect
interestingli
demonstr
enhanc
express
via
supplement
sulforaphan
sfn
epigallocatechin
gallat
egcg
increas
antivir
mediat
absenc
viral
infect
also
abrog
viral
entri
taken
togeth
data
consist
conclus
gene
express
import
modifi
suscept
influenza
primari
human
nec
obtain
previous
describ
briefli
nec
obtain
healthi
adult
volunt
gentli
stroke
inferior
surfac
turbin
sever
time
rhinoprob
curett
arlington
scientif
arlington
tx
insert
nasoscop
select
criteria
recruit
subject
similar
describ
previous
protocol
approv
univers
north
carolina
school
medicin
institut
review
board
biomed
research
primari
human
nasal
epitheli
cell
expand
passag
bronchial
epitheli
growth
medium
begm
cambrex
bioscienc
walkersvil
inc
walkersvil
md
plate
collagenco
filter
support
pore
size
transclr
costar
cambridg
cultur
mixtur
bronchial
epitheli
cell
basic
medium
bebm
dmemh
singlequot
supplement
cambrex
bovin
pituitari
extract
mgml
bovin
serum
albumin
bsa
nystatin
unit
confluenc
alltran
retino
acid
ad
medium
establish
air
liquid
interfac
ali
cultur
condit
remov
apic
medium
promot
differenti
mucociliari
differenti
achiev
day
postali
cell
line
purchas
genhunt
nashvil
tn
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
atlanta
biolog
lawrencevil
ga
penicillinstreptomycin
hyclon
waltham
humidifi
atmospher
cell
line
deriv
transform
human
bronchial
cell
adenoviru
viru
construct
obtain
cell
american
type
cultur
collect
atcc
manassa
va
cell
grown
keratinocyt
basal
medium
kbm
supplement
bovin
pituitari
extract
ngml
human
epiderm
growth
factor
ngml
hydrocortison
mm
ethanolamin
mm
phosphoethanolamin
ngml
insulin
viruslik
particl
vlp
entri
assay
gener
fusion
express
plasmid
influenza
apuerto
sinai
sequenc
pcramplifi
express
vector
pdzm
kindli
provid
dr
adolfo
garciasastr
mount
sinai
school
medicin
insert
pcagg
vector
gene
pcramplifi
fuse
ntermin
within
pcagg
creat
modifi
fusion
modifi
first
amino
acid
exclud
remov
secret
signal
substitut
asp
creat
optim
kozak
consensu
sequenc
construct
describ
previous
influenza
apuerto
sinai
ha
pcaggsha
na
pdzna
overexpress
vector
gener
provid
dr
aldolfo
garciasastr
describ
previous
gener
influenza
vlp
cell
cotransfect
pcaggsha
pdzna
use
fugen
hd
roch
appli
scienc
indianapoli
accord
manufactur
instruct
supernat
contain
vlp
collect
h
posttransfect
clarifi
float
cell
debri
centrifug
rpm
min
vlp
concentr
lowspe
centrifug
amicon
ultra
centrifug
filter
unit
millipor
billerica
retent
aliquot
store
target
cell
seed
either
plate
chamber
slide
labtek
chamber
slide
nalg
nunc
intern
napervil
il
h
cell
wash
hbss
vlp
ad
total
volum
format
volum
chamber
slide
cell
incub
h
cell
wash
twice
hbss
remov
unbound
viru
infect
cell
detect
use
geneblaz
fret
vivo
cellbas
assay
system
substrat
accord
manufactur
recommend
invitrogen
infect
cell
visual
use
nikon
laser
scan
confoc
microscop
use
suggest
excit
emiss
filter
set
imag
process
use
freeview
softwar
nikon
instrument
melvil
ny
quantifi
use
polarstar
optima
plate
reader
bmg
labtech
inc
determin
effect
viral
entri
modul
express
achiev
transfect
either
cmvdriven
human
express
plasmid
lentivir
vector
use
fugen
hd
roch
appli
scienc
indianapoli
accord
manufactur
instruct
h
prior
vlp
entri
assay
similarli
endogen
express
induc
via
supplement
either
sfn
sigmaaldrich
st
loui
mo
egcg
sigmaaldrich
h
prior
perform
entri
assay
experi
use
influenza
serotyp
propag
embryon
hen
egg
viru
collect
allanto
fluid
titer
tissu
cultur
infecti
dose
madindarbi
canin
kidney
cell
hemagglutin
describ
stock
viru
aliquot
store
use
unless
otherwis
indic
infect
cell
infect
approxim
hemagglutin
unit
hau
influenza
bangkok
result
approxim
cell
infect
influenza
h
postinfect
total
rna
total
protein
basolater
supernat
apic
wash
collect
h
postinfect
influenza
viru
titer
apic
wash
determin
tissuecultur
infecti
dose
madin
darbi
canin
kidney
mdck
cell
evalu
use
agglutin
red
blood
cell
indic
accord
modifi
protocol
describ
briefli
mdck
cell
grown
roundbottom
plate
inocul
viruscontain
sampl
dilut
serumfre
mem
contain
trypsin
use
dilut
day
incub
suspens
human
erythrocyt
ad
well
well
exhibit
hemagglutin
consid
posit
viru
titer
express
log
tcid
cell
lysat
prepar
h
postinfect
passiv
lysi
buffer
promega
madison
wi
proteas
inhibitor
mixtur
cocktail
set
iii
calbiochem
san
diego
ca
well
phosphatas
inhibitor
mm
navo
mm
ice
min
centrifug
total
protein
concentr
determin
bradford
protein
assay
biorad
cell
lysat
subject
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
transfer
nitrocellulos
schleicher
schuell
bioscienc
keen
nh
protein
detect
use
specif
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
enzo
life
scienc
plymouth
meet
pa
us
biolog
swampscott
use
load
control
antigenantibodi
complex
stain
antirabbit
antimous
horseradish
peroxidas
hrp
conjug
antibodi
santa
cruz
biotechnolog
detect
supersign
west
pico
chemiluminesc
substrat
pierc
rockford
il
shrna
hairpin
oligonucleotid
shown
design
select
site
human
complet
mrna
ncbi
refer
sequenc
optim
sirna
target
mrna
random
sequenc
lvscrambl
predict
homolog
human
genom
transcript
sequenc
singlestrand
synthet
oligonucleotid
invitrogen
corp
valcencia
ca
incorpor
senseantisens
sequenc
stemloop
motif
pcramplifi
use
primer
forward
revers
result
shrna
pcr
product
subclon
modifi
lentivir
transfer
vector
gipz
thermo
fisher
scientif
inc
birmingham
al
xhoi
bamhi
site
construct
verifi
fluoresc
dna
capillari
sequenc
clone
strategi
nest
shrna
fragment
adaptor
within
untransl
region
green
fluoresc
protein
gfp
report
gene
control
cmv
promot
cell
seed
plate
kgm
media
h
postseed
media
replac
serumfre
media
cell
infect
lentiviru
multipl
infect
moi
ensur
effici
infect
h
postinfect
complet
media
ad
cell
incub
overnight
infect
nec
perform
similarli
modif
briefli
nec
infect
apic
side
moi
incub
overnight
complet
media
remain
unchang
basallater
side
h
postinfect
viru
remov
apic
surfac
reestablish
ali
condit
cell
cotransfect
cm
dish
purifi
lvscrambl
transfer
vector
plasmid
lentivir
pack
mix
open
biosystem
huntsvil
al
accord
manufactur
instruct
h
posttransfect
cell
cultur
medium
replac
ml
fresh
dmem
cell
incub
addit
h
medium
harvest
detach
cell
pellet
centrifug
min
result
supernat
individu
transfect
concentr
lowspe
centrifug
amicon
ultra
centrifug
filter
unit
millipor
billerica
retent
aliquot
store
determin
viral
titer
cell
stabli
express
tetoff
clontech
mountain
view
ca
transactiv
transduc
lentivir
stock
dilut
rang
viral
titer
determin
h
posttransduct
count
green
fluoresc
coloni
encod
vector
fluoresc
microscopi
multipli
coloni
count
dilut
volum
factor
total
rna
extract
use
trizol
invitrogen
accord
supplier
instruct
firststrand
cdna
synthesi
realtim
rtpcr
perform
describ
previous
use
commerci
avail
primer
probe
ha
rigi
mxa
inventori
taqman
gene
express
assay
purchas
appli
biosystem
foster
citi
ca
primer
probe
previous
describ
fluoresc
analysi
gfp
report
identifi
lentivir
transduc
cell
fluoresc
visual
nikon
laser
scan
confoc
microscop
use
suggest
excit
emiss
filter
set
imag
process
use
freeview
softwar
nikon
instrument
melvil
ny
view
activ
viru
entri
assay
fluoresc
visual
nikon
laser
scan
confoc
microscop
use
suggest
excit
emiss
filter
set
imag
process
use
freeview
softwar
equal
adjust
perform
imag
achiev
maximum
clariti
shrna
lentivirusmedi
knockdown
mrna
protein
express
nec
master
transcript
regul
phase
ii
antioxid
pathway
oxid
stress
determin
role
play
suscept
influenza
util
lentivir
vector
express
shrna
effect
decreas
mrna
protein
express
transduc
human
differenti
nec
healthi
volunt
separ
vector
express
scrambl
nonspecif
sequenc
use
neg
control
determin
abil
lentiviru
transduc
differenti
nec
infect
multipl
infect
analyz
cell
presenc
gfp
express
encod
transcript
shrna
h
postinfect
fig
effici
lentiviru
knock
gene
express
measur
isol
total
rna
transduc
cell
util
realtim
rtpcr
quantit
mrna
transcript
normal
cellular
express
mrna
express
significantli
knock
lentiviru
compar
control
lentiviru
lvscrambl
fig
western
blot
analysi
confirm
express
protein
well
gene
reduc
correl
mrna
suppress
fig
next
want
evalu
suppress
affect
viral
replic
cell
infect
influenza
h
posttransduct
lentivir
vector
lvscrambl
total
rna
subject
realtim
rtpcr
quantit
influenza
viral
hemagglutinin
transcript
ha
fig
depict
saw
signific
increas
amount
viral
ha
mrna
produc
cell
knock
compar
control
similarli
analyz
apic
wash
influenza
viral
titer
saw
signific
increas
viral
replic
cell
suppress
express
compar
control
fig
valid
suppress
time
viral
infect
cellular
lysat
use
analyz
protein
level
fig
western
blot
analysi
show
express
level
significantli
reduc
preand
postinfluenza
infect
result
demonstr
knockdown
significantli
increas
viral
replic
nec
previou
report
shown
gene
express
induc
via
antioxid
supplement
specif
addit
polyphenol
catechin
organosulfur
compound
sulforaphan
compound
abil
induc
gene
express
base
initi
dose
studi
determin
concentr
suffici
detect
effect
sfn
egcg
gene
express
nec
vitro
caus
cytotox
data
shown
therefor
nec
treat
either
sfn
egcg
h
prior
infect
influenza
viru
explor
effect
antioxid
compound
viral
replic
total
rna
isol
result
cdna
quantifi
rtpcr
measur
level
influenza
ha
transcript
present
shown
fig
sfn
egcg
inhibit
viral
replic
mark
decreas
ha
gene
express
collect
apic
wash
perform
viral
titer
assay
result
show
egcg
significantli
reduc
viral
replic
sfn
minim
affect
fig
western
blot
reveal
addit
sfn
egcg
increas
protein
level
egcg
enhanc
express
approxim
compar
vehicl
fig
taken
togeth
result
indic
induct
via
antioxid
supplement
suppress
influenza
viru
replic
nec
determin
whether
effect
egcg
replic
inde
mediat
perform
experi
wherebi
nec
transduc
either
lvscrambl
prior
treatment
egcg
fig
show
effect
suppress
effect
egcg
viral
replic
elimin
cell
knockeddown
express
suggest
causal
relationship
egcginduc
activ
abil
protect
viral
replic
determin
potenti
mechan
mediat
suppress
viral
replic
due
antioxid
pretreat
assess
whether
innat
antivir
immun
respons
mediat
modul
specif
analyz
express
retino
acid
induc
gene
rigi
interferoninduc
human
mxa
nec
treat
either
sfn
egcg
state
total
rna
isol
rtpcr
perform
quantit
amount
cellular
transcript
independ
influenza
infect
interestingli
show
antioxid
supplement
specif
egcg
significantli
increas
mrna
express
level
three
antivir
gene
compar
vehicl
alon
fig
data
demonstr
even
absenc
prior
viral
infect
addit
sfn
egcg
significantli
increas
antivir
mediat
express
deciph
step
viru
life
cycl
affect
activ
develop
enzymat
viruslik
particl
assay
similar
previou
report
experi
util
wellcharacter
cell
line
cell
infect
viruslik
particl
express
hemagglutinin
ha
neuraminidas
na
matrix
protein
along
function
report
fusion
vlp
prior
load
fluorogen
substrat
fig
show
microscopi
live
cell
vlp
enter
cell
cleav
substrat
green
disrupt
fret
result
emiss
nm
blue
demonstr
feasibl
assay
determin
effect
express
level
viru
entri
cell
transfect
either
lentivir
vector
knockdown
express
cmvdriven
overexpress
cdna
plasmid
result
show
suppress
result
signific
increas
viral
entri
entri
block
overexpress
fig
final
want
verifi
antioxid
supplement
involv
entri
portion
viru
life
cycl
cell
pretreat
either
sfn
egcg
prior
infect
vlp
shown
fig
antioxid
supplement
significantli
decreas
viral
entri
data
confirm
cellular
express
level
play
role
viral
replic
one
mode
action
reduc
viral
entri
exact
role
oxid
stress
viral
replic
andor
pathogenesi
remain
fulli
defin
airway
epitheli
cell
major
sourc
antioxid
enzym
defens
mediat
lung
also
primari
target
influenza
infect
import
determin
role
cellular
antioxid
mechan
viral
pathogenesi
multifunct
transcript
factor
play
role
chronic
lung
diseas
defens
oxid
well
host
defens
respiratori
viral
infect
although
shown
oxid
stress
increas
viral
infect
antioxid
thought
protect
influenza
exact
mechan
happen
role
respons
yet
elucid
use
genet
pharmacolog
manipul
gene
express
result
demonstr
human
epitheli
cell
gene
express
regul
suscept
influenza
level
antivir
mediat
express
viral
entri
goal
studi
understand
role
gene
express
play
regul
suscept
respiratori
viru
infect
influenza
fulli
differenti
human
primari
nasal
epitheli
cell
previou
studi
shown
mice
develop
enhanc
virusinduc
inflammatori
mucu
cell
metaplast
chang
demonstr
decreas
viral
clearanc
infect
respiratori
syncyti
viru
rsv
pretreat
mice
potent
agent
sulforaphan
sfn
result
increas
level
antioxid
includ
heme
oxygenas
improv
viral
clearanc
reduc
virusassoci
inflamm
studi
show
clear
associ
reduc
express
enhanc
suscept
respiratori
viru
infect
mice
vivo
cell
type
mechan
mediat
effect
remain
unclear
util
human
differenti
nec
transduc
express
shrna
target
data
show
gene
express
play
protect
role
influenza
viru
level
epithelium
specif
data
show
express
affect
influenza
viru
entri
replic
epitheli
cell
influenza
viru
life
cycl
divid
four
basic
stage
attach
entri
replic
egress
depend
part
host
cell
infect
epitheli
cell
numer
hostcelldepend
factor
affect
control
influenza
viru
attach
uptak
proteolyt
cleavag
viral
ha
host
cellderiv
serin
proteas
ii
host
cellderiv
innat
immun
defens
molecul
aim
bind
neutral
infecti
virion
iii
antivir
mediat
limit
viral
replic
shed
viru
particl
modif
sever
factor
alter
express
could
affect
suscept
infect
result
demonstr
increas
activ
significantli
reduc
express
viral
ha
gene
well
influenza
viru
titer
fig
dissect
specif
point
viru
life
cycl
could
determin
role
gene
express
play
viral
suscept
andor
viral
replic
ultim
dictat
viral
pathogenesi
outcom
develop
enzymat
viruslik
particl
assay
adapt
previou
studi
use
vlp
studi
hiv
ebola
viru
entri
data
demonstr
genet
pharmacolog
manipul
express
significantli
affect
influenza
viru
entri
fig
suppress
express
increas
influenza
viru
entri
increas
express
reduc
viral
entri
thu
protect
cell
viral
infect
report
first
identifi
mechan
action
context
influenza
viru
life
cycl
mechan
oxid
stress
andor
modifi
express
alter
influenza
viru
entri
clear
base
previou
report
hypothes
increas
viral
entri
subsequ
replic
seen
cell
reduc
express
activ
mediat
activ
host
cellular
transmembran
proteas
indic
regul
proteolysi
requir
spreadpropag
mani
human
virus
includ
human
immunodefici
viru
hiv
nipah
ebola
sever
acut
respiratori
syndrom
coronaviru
sarscov
metapneumovirus
influenza
previou
studi
demonstr
import
proteasespecif
cellular
proteasesantiproteas
involv
influenza
infect
includ
transmembran
proteas
serin
human
airway
trypsinlik
proteas
hat
secretori
leukocyt
proteinas
inhibitor
slip
express
proteas
lung
necessari
cleavag
viral
ha
surfac
protein
thu
allow
viral
fusion
entri
host
cell
studi
shown
correl
inflamm
oxid
stress
lead
alter
express
proteasesantiproteas
specif
hat
shown
releas
airway
fluid
inflammatori
condit
particularli
asthmat
murin
studi
show
slpi
gene
express
increas
mice
led
increas
inflamm
demonstr
balanc
oxid
stress
proteas
express
studi
combin
data
present
lead
us
hypothes
oxid
stress
propag
via
decreas
gene
express
caus
increas
serin
proteas
activ
culmin
increas
effici
ha
cleavag
thu
increas
viron
entri
demonstr
fig
interestingli
result
demonstr
supplement
sfn
greater
extent
egcg
increas
protein
level
also
induc
express
three
wellcharacter
antivir
respons
gene
includ
rigi
mxa
fig
noteworthi
increas
express
antivir
gene
induc
via
supplement
egcg
absenc
viral
infect
known
infect
replic
virus
result
accumul
intracellular
ssrna
dsrna
host
cell
trigger
multipl
host
respons
mechan
includ
express
type
inf
mxa
rigi
viral
infect
normal
induc
product
type
ifn
turn
activ
synthesi
numer
interferonstimul
gene
isg
isg
collect
induc
antivir
state
host
cell
well
neighbor
cell
thu
limit
viral
replic
cell
one
isg
mxa
belong
small
famili
gtpase
shown
inhibit
viral
replic
mxa
also
display
antivir
activ
toward
influenza
viru
anoth
ifninduc
gene
rigi
cytosol
dexdh
boxcontain
rna
helicas
interact
dsrna
augment
interferon
product
respons
viral
infect
demonstr
treatment
egcg
absenc
viral
infect
increas
mrna
express
level
rigi
appear
contrast
recent
studi
show
egcg
suppress
rigi
signal
studi
identifi
small
molecul
screen
egcg
bind
rigi
report
certain
concentr
egcg
effici
bind
rigi
interf
rigi
abil
bind
rna
suppress
rigi
signal
howev
studi
perform
cell
line
could
contribut
somewhat
conflict
result
base
observ
hypothes
egcg
upregul
express
antivir
gene
proactiv
protect
cell
prior
viral
infect
induc
antivir
protect
state
possibl
rigi
mxa
gene
may
contain
bind
site
promot
region
induct
would
thu
increas
transcript
antivir
gene
howev
least
knowledg
essenti
bind
site
identifi
promot
gene
list
studi
examin
gene
express
profil
mice
report
differ
antivir
interferon
respons
gene
conceiv
effect
sfn
egcg
rigi
mxa
express
independ
effect
speci
andor
celltyp
specif
sfn
egcg
shown
potent
antioxid
capac
part
induc
express
number
antioxid
enzym
vitro
vivo
studi
shown
supplement
potent
induc
express
phase
ii
antioxid
gene
associ
respons
element
epr
signal
mechan
activ
induct
involv
serinethreonin
phosphoryl
lead
increas
nuclear
accumul
bind
epr
whether
activ
gene
express
involv
potenti
antivir
effect
known
data
show
egcg
lesser
extent
sfn
modifi
influenza
replic
human
respiratori
epitheli
cell
concentr
effect
egcg
viral
replic
abolish
cell
knockeddown
express
fig
like
higher
concentr
sfn
would
yield
signific
effect
viral
replic
observ
similar
previou
mous
vivo
studi
show
supplement
sfn
reduc
rsv
infect
mice
mice
previou
studi
indic
egcg
directli
bind
influenza
viru
therefor
prevent
attach
entri
host
cell
howev
studi
conduct
mdck
cell
natur
host
cell
influenza
requir
addit
exogen
proteas
achiev
viral
entri
data
demonstr
supplement
differenti
nec
either
sfn
egcg
basolater
side
elimin
direct
interact
viru
infect
significantli
decreas
influenza
viru
entri
replic
effect
depend
fig
statu
may
influenc
suscept
viral
exacerb
specif
subpopul
report
protect
lung
oxid
stress
recent
data
describ
function
polymorph
within
gene
human
identifi
suscept
gene
increas
risk
acut
lung
injuri
report
also
identifi
role
pulmonari
diseas
associ
oxid
stress
chronic
obstruct
pulmonari
diseas
copd
asthma
viral
infect
shown
exacerb
diseas
understand
orchestr
cellular
defens
mechan
may
provid
insight
develop
novel
intervent
prevent
strategi
target
oxid
airway
diseas
investig
antioxid
supplement
treatment
along
potenti
inhibitor
influenzaactiv
type
ii
transmembran
serin
proteas
ttsp
could
import
addit
current
antivir
therapi
includ
target
neuraminidas
ion
channel
influenza
infect
remain
major
global
public
health
concern
understand
mechan
modul
suscept
influenza
infect
vast
impact
morbid
mortal
ultim
infect
outcom
summari
work
provid
insight
identifi
understand
new
molecular
pathway
gene
express
potenti
protect
cell
viral
infect
work
demonstr
activ
gene
express
prior
influenza
abrog
viral
entri
replic
also
found
transcript
factor
play
critic
role
dictat
suscept
viral
infect
level
epithelium
shown
nutrit
supplement
sfn
egcg
increas
level
also
increas
express
multipl
antivir
mediat
absenc
viral
infect
hypothes
induct
antivir
mediat
turn
initi
antivir
state
prime
cell
viral
infect
thu
limit
viru
entri
replic
previou
studi
demonstr
human
oral
administ
sfn
dose
yield
peak
plasma
level
reach
similarli
previou
studi
determin
pharmacokinet
egcg
human
report
singl
dose
mmol
oral
administ
egcg
achiev
peak
plasma
concentr
averag
thu
level
sfn
egcg
shown
antivir
effect
clinic
feasibl
studi
aim
use
oral
administ
sfn
egcg
may
provid
greater
insight
potenti
novel
antivir
therapeut
intervent
research
also
support
grant
nieh
curriculum
toxicolog
train
grant
